EPFX, QXCI, SCIO. A box that claims to test thousands of substances against the body in seconds, built by a man who left the United States rather than face charges and manufactured it from Budapest. The Americans stopped it at the border. What Canada did, we cannot show you.
The device has gone by several names — the Quantum Xrroid Consciousness Interface, the QXCI, the EPFX or Electro Physiological Feedback Xrroid, and latterly the SCIO. The names matter, because changing them is part of how the machine has stayed in circulation.
Physically it is a small interface box connected to a computer, with straps or electrodes placed on the head, wrists and ankles. The software is the product. It is claimed to read the body's reactivity to thousands of substances and conditions, and then to send frequencies back to correct what it finds. The word Xrroid was coined by its inventor to describe the rapid testing of thousands of items in a very short time by electrophysiological means.
In technique and in ancestry this belongs to the same family as the instruments documented on our EAV and Vegatest page: a low-current measurement dressed as a diagnosis, with a software layer supplying an answer the hardware cannot possibly generate.
| The claim | What the record shows | Verdict |
|---|---|---|
| It tests thousands of substances against the patient in minutes. | No measurement performed at the skin can distinguish the body's response to thousands of separate substances that were never administered. What the software reports is generated by the software. This is the defining feature of radionics, and the device is classified as a radionics instrument. | Not possible |
| It loops all of the body's cells into a multi-channel biofeedback system. | Marketing language with no physiological content. Genuine biofeedback measures one or a few real parameters — heart rate, skin conductance, muscle tension — and shows them to the patient. It does not survey cells. | Meaningless |
| It is the most advanced medical assessment and therapy device in the world. | A promotional claim from the manufacturer's own material. No clinical trial supports any diagnostic or therapeutic use. | Unsupported |
| It is registered, cleared or approved. | This is where the device family does its most careful work. It is not legally marketable in the United States as a diagnostic or treatment device. Distributors have historically worked around that by presenting it as a biofeedback device for stress reduction — a description that carries a much lower regulatory burden and bears no relation to how the machine is actually used on patients. | Reframed |
| It sends corrective frequencies back into the body. | There is no evidence that any of the claimed therapeutic effects occur, and no mechanism by which they could. The claimed treatment indications have at various times included serious disease. | No evidence |
The economics are worth recording alongside the claims. In 2002 the interface, software, manual and basic training were priced at around $13,000, with used units reportedly changing hands at about $8,000. The manufacturer has stated that more than three thousand units were sold worldwide. Whatever else this is, it is a substantial business.
The device was developed by William C. Nelson, born 1951, who has also been known by a female stage identity under which much of the later promotional material appears. Promotional accounts describe a distinguished scientific and medical career.
He has not been in the United States for a long time. He left in the face of criminal charges and has lived in Hungary, where the manufacturer, QX Ltd, is based in Budapest. He remained a fugitive from those charges.
In 2007 the Seattle Times published a major investigation into energy medicine devices, describing an industry of thousands of machines — many of them illegal or dangerous — in use across hundreds of American venues, and characterising the field as modern-day snake oil sold on unproven or false claims.
Action followed. In January 2008 the QXCI/EPFX and another device were barred by United States authorities. The mechanism was an FDA import alert, which stops the product at the border rather than pursuing every seller inside the country — and the alert sets out what the device was and was not given marketing clearance for. By one contemporaneous account the manufacturing entity behind the EPFX closed in February 2009.
The device did not disappear. It continued to be sold internationally under the SCIO name, marketed on a different registration in Europe as a universal electrophysiological system, with a broad set of indications. Related systems marketed by former associates of the inventor have circulated under other names again.
Here is the claim, which appears in reference works, in trade discussion and in the marketing of competing devices: that in February 2009, following a CBC investigation featuring an interview with the inventor, Health Canada banned the EPFX from sale in Canada.
We have tried to source it properly, and we cannot.
Every trail leads to the same two places: a CBC Marketplace broadcast, and a follow-up CBC item asking whether the device was still allowed to be sold in Canada. Reference entries cite those CBC pages. Forum discussion cites the reference entries. Competing manufacturers cite the general proposition without any citation at all. What we have not located is a Health Canada instrument — an advisory with a number, a recall entry, a licence suspension, a stop-sale order, anything that the department itself published and that a reader could check.
What it means is that a reader who wants to verify the most frequently repeated fact about this device in Canada cannot do so from Canadian government sources. Seventeen years on, the Canadian regulatory position on a machine sold here rests on a television programme. That is the finding, and it is a finding about the record rather than about the device.
If you hold any of those, please send it. We would rather print the primary document than keep the flag.
And if you have seen this device advertised or been offered a session on one: the federal and provincial complaint routes, with current contact details verified July 2026, are on How to complain, and to whom. How that compares with the other four devices in this section is set out on Never for the device itself, and the answer is that the gap is in the same place every time.
The rest of this section is our opinion. Everything above it is sourced, including the gap.
The pattern here is the one this whole section keeps running into, and it appears again on our page about the Zapper and the Syncrometer: a device is sold in both countries, the American regulator produces a citable instrument, and the Canadian record consists of a news report about an outcome that was never published.
An import alert is a modest measure. It does not seize what is already in the country, it does not penalise anyone, and it does not reach a practitioner using a machine bought years earlier. But it is written down, numbered, and public, and anyone can look it up and see exactly what was and was not permitted. That is the minimum a regulated market owes the people in it.
We think a decision the public cannot verify is not much of a decision. If Health Canada barred this device in 2009, the department should be able to point to the document. If it did not, the many websites asserting that it did should stop.
It would be reasonable to ask why a device barred from the American market in 2008 deserves a page in 2026. Three reasons.
The device and its claims: Quackwatch's file on the Quantum Xrroid and William C. Nelson, which records the marketing claims, the coined term, the Budapest manufacturer, the 2002 pricing, the reported worldwide sales figure, and the biofeedback reframing used by distributors. Reference material classifying the device as a radionics instrument and recording its naming history.
United States: the Seattle Times investigation into energy medicine devices published in 2007; the January 2008 barring of the QXCI/EPFX; the FDA import alert setting out what the device was and was not cleared for. The statement that the EPFX manufacturing entity closed in February 2009 comes from a 2009 exchange with the manufacturer reproduced by a consumer affairs columnist, and is reported here as that source gives it.
Canada: CBC Marketplace, "Miracle Makers or Money Takers?", and the CBC follow-up item asking whether the EPFX was still allowed to be sold in Canada. All secondary accounts of a Canadian ban that we examined trace back to these two items. No Health Canada advisory, recall entry, licence action or other departmental instrument concerning this device has been located, and none is cited on this page as existing.
We would particularly like a citation to any Health Canada instrument concerning the EPFX, QXCI, SCIO or QX Ltd. Send it and it will be published, and this page will be rewritten around it.